$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

$areb Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017266 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$3.671M	$4.402M	$154.1K
YoY Change	983.7%	2757.02%	-55.89%
Cost Of Revenue	$2.983M	$2.791M	$96.72K
YoY Change	1137.23%	2785.99%	-63.93%
Gross Profit	$687.9K	$1.611M	$57.36K
YoY Change	604.6%	2708.18%	-29.31%
Gross Profit Margin	18.74%	36.59%	37.23%
Selling, General & Admin	$2.041M	$1.532M	$901.3K
YoY Change	43.84%	70.02%	176.62%
% of Gross Profit	296.68%	95.14%	1571.29%
Research & Development		$16.50K	$114.2K
YoY Change		-85.56%	-14.15%
% of Gross Profit		1.02%	199.16%
Depreciation & Amortization	$25.28K	$29.09K	$900.00
YoY Change	5395.65%	3132.22%	-44.1%
% of Gross Profit	3.68%	1.81%	1.57%
Operating Expenses	$2.239M	$1.831M	$1.016M
YoY Change	33.12%	80.11%	120.72%
Operating Profit	-$1.551M	-$219.9K	-$959.1K
YoY Change	-2.1%	-77.07%	152.81%
Interest Expense	$148.4K	$7.110K	-$292.4K
YoY Change	724.6%	-102.43%	-46.66%
% of Operating Profit
Other Income/Expense, Net	$1.108M	-$7.110K
YoY Change
Pretax Income	-$590.2K	-$227.1K	-$2.628M
YoY Change	-63.16%	-91.36%	183.33%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$590.2K	-$227.1K	-$2.628M
YoY Change	-63.16%	-91.36%	183.33%
Net Earnings / Revenue	-16.08%	-5.16%	-1705.76%
Basic Earnings Per Share	-$0.87	-$0.01	-$0.83
Diluted Earnings Per Share	-$0.87	-$0.01	-$829.4K
COMMON SHARES
Basic Shares Outstanding	16.93M shares	16.93M shares	3.169M shares
Diluted Shares Outstanding	679.0K shares	33.50M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.733M	$466.0K	$3.509M
YoY Change	8.9%	-86.72%	11920.14%
Cash & Equivalents	$2.733M	$466.0K	$3.509M
Short-Term Investments
Other Short-Term Assets	$160.3K	$169.9K	$611.5K
YoY Change	-69.73%	-72.22%	1286.91%
Inventory	$8.874M	$8.436M	$1.291M
Prepaid Expenses	$160.3K	$169.9K
Receivables	$1.982M	$2.342M	$162.2K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$13.75M	$11.41M	$5.573M
YoY Change	215.09%	104.81%	406.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$402.2K	$427.4K
YoY Change	2947.57%
Goodwill	$4.200M	$4.200M	$4.200M
YoY Change		0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.716M	$5.955M
YoY Change	120245.07%
Total Long-Term Assets	$6.119M	$6.383M	$0.00
YoY Change	33994.21%		-100.0%
TOTAL ASSETS
Total Short-Term Assets	$13.75M	$11.41M	$5.573M
Total Long-Term Assets	$6.119M	$6.383M	$0.00
Total Assets	$19.87M	$17.80M	$5.573M
YoY Change	353.44%	219.34%	404.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.289M	$2.431M	$114.3K
YoY Change	331.38%	2027.46%	-85.11%
Accrued Expenses	$1.069M	$1.094M	$67.92K
YoY Change	1474.57%	1510.44%	-90.4%
Deferred Revenue
YoY Change
Short-Term Debt	$1.482M	$601.4K	$614.9K
YoY Change	145.02%	-2.19%	-87.69%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.347M	$5.927M	$797.1K
YoY Change	425.39%	643.61%	-87.68%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$521.7K	$743.9K
YoY Change
Total Long-Term Liabilities	$521.7K	$743.9K	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.347M	$5.927M	$797.1K
Total Long-Term Liabilities	$521.7K	$743.9K	$0.00
Total Liabilities	$6.868M	$6.671M	$797.1K
YoY Change	468.59%	736.94%	-88.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.93M	-$34.34M
YoY Change	11.96%
Common Stock	$749.00	$16.93K
YoY Change	-84.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.00M	$11.13M	$4.776M
YoY Change
Total Liabilities & Shareholders Equity	$19.87M	$17.80M	$5.573M
YoY Change	353.44%	219.34%	404.7%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$590.2K	-$227.1K	-$2.628M
YoY Change	-63.16%	-91.36%	183.33%
Depreciation, Depletion And Amortization	$25.28K	$29.09K	$900.00
YoY Change	5395.65%	3132.22%	-44.1%
Cash From Operating Activities	-$784.3K	-$1.691M	-$2.924M
YoY Change	-19.93%	-42.19%	1178.41%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$1.400K	$0.00	$0.00
YoY Change	-110.26%
Cash From Investing Activities	$1.400K
YoY Change	-110.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.050M	$1.800M	6.415M
YoY Change	-55760.95%	-71.95%	3156.01%
NET CHANGE
Cash From Operating Activities	-784.3K	-$1.691M	-2.924M
Cash From Investing Activities	1.400K
Cash From Financing Activities	3.050M	$1.800M	6.415M
Net Change In Cash	2.267M	$109.2K	$0.00
YoY Change	-327.02%
FREE CASH FLOW
Cash From Operating Activities	-$784.3K	-$1.691M	-$2.924M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001648087
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2023Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash		usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2023Q1	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodTotalIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2022Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2022Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2023Q1	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
CY2022Q1	AREB	Total Finance Lease Expense TotalFinanceLeaseExpense		usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost		usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2022Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability		usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour		usd
CY2022Q4	AREB	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour		usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue		usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
CY2023Q1	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41267
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	AMERICAN REBEL HOLDINGS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3892903
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	909 18th Avenue South
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite A
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Nashville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37212
CY2023Q1	dei	City Area Code CityAreaCode	(833)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	267-3235
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	16930517	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	465978	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	356754	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	2342350	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1613489	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	169896	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	207052	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8150255	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	285848	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	309684	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	11414327	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9908675	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	427434	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
CY2023Q1	us-gaap	Deposit Assets DepositAssets	21503	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	18032	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1733829	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1977329	usd
CY2023Q1	us-gaap	Goodwill Goodwill	4200000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4200000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5955332	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6195361	usd
CY2023Q1	us-gaap	Assets Assets	17797093	usd
CY2022Q4	us-gaap	Assets Assets	16560561	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2430835	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2523551	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	103919	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	103919	usd
CY2023Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	101000	usd
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	601446	usd
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	602643	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1700000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	989892	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	992496	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5927092	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4222609	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	743937	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	984833	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1830718	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1016437	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-219945	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-959076	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	7110	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	292405	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1376756	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-227055	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2628237	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6671029	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5207442	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	175000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	175000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16930517	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16930517	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16930517	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16930517	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	16930	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	16930	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45448824	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45448824	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34339865	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11126064	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17797093	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16560561	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4402099	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	154080	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	2791326	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	96719	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1610773	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	57361	usd
CY2023Q1	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	944599	usd
CY2022Q1	AREB	Consulting Payroll And Other Payroll Costs ConsultingPayrollAndOtherPayrollCosts	462989	usd
CY2023Q1	AREB	Rental Expense Warehousing Outlet Expense RentalExpenseWarehousingOutletExpense	226660	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16495	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33273	usd
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	252725	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	80970	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	361149	usd
CY2022Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	438305	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	29090	usd
CY2022Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	900	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-227055	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2628237	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16930000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3169000	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4170337	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9038456	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	969535	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1566559	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	974113	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2628237	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	4775936	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11353119	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-227055	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11126064	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11126064	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-227055	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2628237	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29090	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	900	usd
CY2022Q1	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	969535	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1000457	usd
CY2023Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	728861	usd
CY2022Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	61507	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-37156	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	448000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	704724	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-42360	usd
CY2023Q1	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	3472	usd
CY2022Q1	AREB	Increase Decrease In Inventory Deposits IncreaseDecreaseInInventoryDeposits	647147	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-92713	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1152603	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1690579	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2924242	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9038456	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1700000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	101000	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-81506	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-1197	usd
CY2022Q1	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	60000	usd
CY2022Q1	AREB	Repayments Of Non Related Party Debt RepaymentsOfNonRelatedPartyDebt	2601634	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1799803	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6415316	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	109224	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3491074	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	356754	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17607	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	465978	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3508681	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	25434	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	188607	usd
CY2022Q1	AREB	Debt Repayment Through Issuance Of Common Stock DebtRepaymentThroughIssuanceOfCommonStock	1950224	usd
CY2023Q1	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2014-12-15
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-227055	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2628237	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.67
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Granted Debt Conversion Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualGrantedDebtConversionTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Warrant ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWarrant	11579885	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Warrant Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageWarrantExercisePrice	0.01
CY2023Q1	us-gaap	Fiscal Period FiscalPeriod	<p id="xdx_842_eus-gaap--FiscalPeriod_zxZnBYAqMaOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_863_zi25jRorbDCi">Year-end</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s year-end is December 31.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	252725	usd
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	80970	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.83
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16930000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3169000	shares
CY2023Q1	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	26569000	shares
CY2022	AREB	Total Dilutive Effect Of Outstanding Stock Awards Or Common Stock Equivalents TotalDilutiveEffectOfOutstandingStockAwardsOrCommonStockEquivalents	755000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33499000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3924000	shares
CY2023Q1	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
CY2022	us-gaap	Income Tax Examination Description IncomeTaxExaminationDescription	less than a 50% likelihood
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_849_eus-gaap--UseOfEstimates_zBljvW7RxmDk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_865_zL0VDPz0GaVg">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	AREB	Warrant Liabilities WarrantLiabilities	93458	usd
CY2023Q1	AREB	Warrant Liabilities WarrantLiabilities	106707	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
CY2023Q1	us-gaap	Valuation Allowance Deferred Tax Asset Explanation Of Change ValuationAllowanceDeferredTaxAssetExplanationOfChange	As a result, management determined it was more likely than not deferred tax assets will not be realized as of March 31, 2023, and December 31, 2022, and recognized 100% valuation allowance for each period
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-227055	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2628237	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34339865	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34112810	usd
CY2023Q1	AREB	Working Capital Deficit WorkingCapitalDeficit	6477127	usd
CY2022Q4	AREB	Working Capital Deficit WorkingCapitalDeficit	6678562	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	701776	shares
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8150255	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421696	usd
CY2023Q1	AREB	Inventory Deposits InventoryDeposits	285848	usd
CY2022Q4	AREB	Inventory Deposits InventoryDeposits	309684	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	8436003	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7731380	usd
CY2023Q1	us-gaap	Deposits Deposits	600000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	815859	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	815859	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	388425	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	359334	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	427434	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	456525	usd
CY2023Q1	us-gaap	Depreciation Depreciation	29090	usd
CY2022Q1	us-gaap	Depreciation Depreciation	900	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.80
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2909639	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.1875
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P5Y
CY2022	AREB	By Share Based Payment Award Options Granted Debt Conversion ByShareBasedPaymentAwardOptionsGrantedDebtConversion	377484	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Granted Debt Conversion Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantedDebtConversionExercisePrice	5.1875
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1700000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	1700000	usd
CY2023Q1	us-gaap	Secured Debt SecuredDebt	601466	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	602643	usd
CY2023Q1	us-gaap	Goodwill Goodwill	4200000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	4200000	usd
CY2023Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4200000	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	4200000	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34339865	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	34112810	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7211370	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7163690	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7211370	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	7163690	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7211370	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7163690	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	7211370	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.210	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022Q3	AREB	Corporate Alternative Minimum Income Tax Rate CorporateAlternativeMinimumIncomeTaxRate	0.15	pure
CY2022Q3	AREB	Percentage Ogexcise Tax On Corporate Stock Repurchases PercentageOgexciseTaxOnCorporateStockRepurchases	0.01	pure
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1566659.00	usd
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	377484	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	377484	shares
CY2022Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.1875
CY2022Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	12887976.31	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	509311	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	11202401	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.10
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	11202401	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	11202401	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.01
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	377484	shares
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Warrant Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualWarrantTerm2	P5Y
CY2022	AREB	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period One ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodOne	23423424	shares
CY2022	AREB	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price One ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceOne	0.86
CY2022	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	11957369	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	938	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	27411385	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.00
CY2023Q1	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2	P0Y
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.01
CY2023Q1	AREB	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Exercised Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageExercisedRemainingContractualTerm2	P0Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	27411385	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.22
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y6M
CY2023Q1	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	226660	usd
CY2022Q1	AREB	Rent Expense For Operating Leases RentExpenseForOperatingLeases	0	usd
CY2023Q1	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
CY2022Q1	AREB	Rental Equipment Expense For Finance Leases RentalEquipmentExpenseForFinanceLeases	0	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	226660	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	226660	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1733829	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	243501	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0500	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	862857	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	688526	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	163794	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	62792	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3733	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1781702	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	104664	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1677038	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	226660	usd
CY2021	us-gaap	Payments For Rent PaymentsForRent	0	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	0	usd

Files In Submission

Name	View Source	Status
areb-20230331_pre.xml	Edgar Link	unprocessable
0001493152-23-017266-index-headers.html	Edgar Link	pending
0001493152-23-017266-index.html	Edgar Link	pending
0001493152-23-017266.txt	Edgar Link	pending
0001493152-23-017266-xbrl.zip	Edgar Link	pending
areb-20230331.xsd	Edgar Link	pending
areb-20230331_cal.xml	Edgar Link	unprocessable
areb-20230331_def.xml	Edgar Link	unprocessable
areb-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex4-6.htm	Edgar Link	pending
ex4-6_001.jpg	Edgar Link	pending
ex4-6_002.jpg	Edgar Link	pending
ex4-6_003.jpg	Edgar Link	pending
ex4-6_004.jpg	Edgar Link	pending
ex4-6_005.jpg	Edgar Link	pending
ex4-6_006.jpg	Edgar Link	pending
ex4-6_007.jpg	Edgar Link	pending
ex4-6_008.jpg	Edgar Link	pending
ex4-6_009.jpg	Edgar Link	pending
ex4-6_010.jpg	Edgar Link	pending
ex4-6_011.jpg	Edgar Link	pending
ex4-6_012.jpg	Edgar Link	pending
ex4-6_013.jpg	Edgar Link	pending
ex4-6_014.jpg	Edgar Link	pending
ex4-6_015.jpg	Edgar Link	pending
ex4-6_016.jpg	Edgar Link	pending
ex4-6_017.jpg	Edgar Link	pending
ex4-6_018.jpg	Edgar Link	pending
ex4-6_019.jpg	Edgar Link	pending
ex4-6_020.jpg	Edgar Link	pending
ex4-6_021.jpg	Edgar Link	pending
ex4-6_022.jpg	Edgar Link	pending
ex4-6_023.jpg	Edgar Link	pending
ex4-6_024.jpg	Edgar Link	pending
ex4-6_025.jpg	Edgar Link	pending
ex4-6_026.jpg	Edgar Link	pending
ex4-6_027.jpg	Edgar Link	pending
ex4-6_028.jpg	Edgar Link	pending
ex4-6_029.jpg	Edgar Link	pending
ex4-6_030.jpg	Edgar Link	pending
ex4-6_031.jpg	Edgar Link	pending
ex4-6_032.jpg	Edgar Link	pending
ex4-6_033.jpg	Edgar Link	pending
ex4-6_034.jpg	Edgar Link	pending
ex4-6_035.jpg	Edgar Link	pending
ex4-6_036.jpg	Edgar Link	pending
ex4-6_037.jpg	Edgar Link	pending
ex4-6_038.jpg	Edgar Link	pending
ex4-6_039.jpg	Edgar Link	pending
ex4-6_040.jpg	Edgar Link	pending
ex4-6_041.jpg	Edgar Link	pending
ex4-6_042.jpg	Edgar Link	pending
ex4-6_043.jpg	Edgar Link	pending
ex4-6_044.jpg	Edgar Link	pending
ex4-6_045.jpg	Edgar Link	pending
ex4-6_046.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb

2023 Q2 Form 10-Q Financial Statement

#000149315223017266 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB AMERICAN REBEL HOLDINGS INC Stock $areb

2023 Q2 Form 10-Q Financial Statement

#000149315223017266 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AREB
AMERICAN REBEL HOLDINGS INC Stock $areb